NGVT · Ingevity Corp · Documents

$61.72 -0.25 (-0.40%) At close · Nov 13 Play latest call Q3 2026 earnings call transcript

S&P 600 member Russell 2000 member Rebalance outlook locked

Market Cap

$2.08B

33.78M

Volume · Nov 13 233.97K Avg daily vol (3M) 298.49K

The company's filings, earnings calls and investor events, most recent first. Search and read these filings from Claude or ChatGPT with the SEC filings MCP server →

Annual report FY2025 Revenue $1.17B down 2.7% 10-K filed Feb 26, 2026 Quarterly report FY2026 Q3 Revenue $305.1M down 8.4% 10-Q filed Nov 5, 2026 Latest results Third-quarter earnings rise as adjusted EBITDA outlook narrows 8-K filed Nov 4, 2026 Earnings call Q3 2026 earnings call Held Nov 5, 2026

2026

Nov 5

Quarterly report 10-Q FY2026 Q3, ended Sep 30

Net income rose as sales declined and outlook narrowed

Ingevity Corporation reported net income of $49.3 million for the three months ended September 30, 2026, versus $43.5 million in 2025, while net sales declined to $305.1 million from $333.1 million. Full-year adjusted EBITDA guidance is $385 million to $395 million.

Revenue $305.1M ▼ 8.4% Net income $49.3M ▲ 13.3% Diluted EPS $1.41 ▲ 19.5%

Read from the MD&A section

6 source passages

Ingevity Corporation provides products and technologies that purify, protect, and enhance the world around us. #### Three Months Ended September 30, 2026 vs. 2025 | Net sales | 305.1 | 333.1 | 877.2 | 912.5 | | Net income (loss) | 49.3 | 43.5 | 144.4 | (82.5) | We are narrowing our full-year adjusted EBITDA outlook, while maintaining the midpoint of the prior range, supported by solid year-to-date performance and increased visibility into expected results for the remainder of the year. Adjusted EBITDA is expected to be between $385 million and $395 million for 2026. Open the document at this passage

Nov 5

Earnings call

Adjusted EBITDA outlook narrowed; buybacks and EPS rise

Ingevity narrowed full-year adjusted EBITDA guidance to $385 million to $395 million. Third-quarter adjusted EPS rose approximately 24% to $1.63, and $39 million in shares were repurchased.

4 source passages

Ingevity is becoming a stronger, more focused company with resilient margins, strong cash generation. Differentiated technologies, and multiple paths to organic growth. With three-quarters of the year behind us, we are narrowing our full-year adjusted EBITDA outlook to $385 million to $395 million, maintaining the $390 million midpoint of our prior range. Adjusted earnings per share was $1.63 compared to $1.31 in the prior year quarter, an increase of approximately 24%. We repurchased approximately $39 million of shares during the quarter, bringing year-to-date repurchases to approximately $125 million, with $172 million of capacity remaining on our current authorization. Open the document at this passage

Nov 4

Current report 8-K

Third-quarter earnings rise as adjusted EBITDA outlook narrows

Ingevity reported third-quarter net sales of $305.1 million, down 8%, and net income from continuing operations of $51.1 million, or $1.46 per diluted share. It narrowed 2026 adjusted EBITDA guidance to $385 million to $395 million.

Financial results

4 source passages

Net sales of $305.1 million decreased 8% from prior year; excluding Road Markings, sales increased 2% Net income from continuing operations of $51.1 million, or $1.46 per diluted share, compared to $40.8 million, or $1.10 per diluted share, in the prior year Narrows full year adjusted EBITDA outlook to a range of $385 million to $395 million, maintaining the midpoint of the prior range Ingevity Corporation (NYSE: NGVT) today reported its financial results for the third quarter of 2026. Open the document at this passage

Jul 30

Quarterly report 10-Q FY2026 Q2, ended Jun 30

Quarterly report for FY2026 Q2 AI summary on its way

Revenue $314.1M ▼ 5.2% Net income $35.3M Diluted EPS $1.00

Jul 30

Earnings call

Q2 2026 earnings call AI summary on its way

Jul 29

Current report 8-K

Financial results AI summary on its way

Jun 24

Current report 8-K Events of Jun 22